Abivax (AAVXF) Change in Cash (2024 - 2026)

Abivax has reported Change in Cash for 3 years, with the latest figure at -$46.0 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 7.51% year-over-year to -$46.0 million in Q1 2026; TTM through Mar 2026 was $433.6 billion, a 476.55% increase from a year earlier, with the FY2025 full-year figure at $433.6 billion, up 476.66% from the prior year.
• Change in Cash was -$46.0 million for Q1 2026 at Abivax, down from $433.0 billion in the prior quarter.
• The five-year high for Change in Cash was $433.0 billion in Q4 2025, with the low at -$115.0 billion in Q4 2024.
• Average Change in Cash over 3 years is $35.4 billion, with a median of -$42.8 million recorded in 2025.
• The largest YoY upside for Change in Cash was 1444.43% in 2025 against a maximum downside of 280.84% in 2025.
• Over 3 years, Change in Cash stood at -$115.0 billion in 2024, then soared by 476.45% to $433.0 billion in 2025, then sank by 100.01% to -$46.0 million in 2026.
• The last three Change in Cash figures came in at -$46.0 million (Q1 2026), $433.0 billion (Q4 2025), and $618.1 million (Q3 2025), per Business Quant data.